In the judgment of 1 April 2013 on Novartis AG v. Union of India & Others the Supreme Court of India have denied that frivolous innovations of a patented medicine can be patented as a new drug under the Indian Patents Act. The Court has come to this conclusion because this Act aims to promote universal access to essential drugs by facilitating the production and exportation of cheap generic drugs. The article focuses on the relationship between the access to essential drugs and the guaranty of the right to health at the level of international law. For the purpose of the protection of such a right, the reduction of the price of essential drugs is important, but not sufficient, as emphasized by the UN Committee of the Economic, Social and Cultural Covenant, in particular within its General Comment on the right to health, and by the Special Rapporteur on the right to health of the UN Council of Human Rights within several reports. To this end, States and other actors of international relations, such as multinational enterprises, should promote the satisfaction of the social needs of developing countries as a whole.
La riduzione del prezzo dei farmaci essenziali: uno strumento necessario ma non sufficiente per la tutela della salute nel quadro del diritto internazionale
ACCONCI, Pia
2013-01-01
Abstract
In the judgment of 1 April 2013 on Novartis AG v. Union of India & Others the Supreme Court of India have denied that frivolous innovations of a patented medicine can be patented as a new drug under the Indian Patents Act. The Court has come to this conclusion because this Act aims to promote universal access to essential drugs by facilitating the production and exportation of cheap generic drugs. The article focuses on the relationship between the access to essential drugs and the guaranty of the right to health at the level of international law. For the purpose of the protection of such a right, the reduction of the price of essential drugs is important, but not sufficient, as emphasized by the UN Committee of the Economic, Social and Cultural Covenant, in particular within its General Comment on the right to health, and by the Special Rapporteur on the right to health of the UN Council of Human Rights within several reports. To this end, States and other actors of international relations, such as multinational enterprises, should promote the satisfaction of the social needs of developing countries as a whole.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
